Why the study?
Does correction of anaemia with erythropoietin and iron improve cardiac and renal outcomes in patients with cardio-renal anaemia syndrome?
Population
Patients with anaemia, chronic kidney insufficiency, and congestive heart failure
Design
Review
Authors
Loading...
May support anaemia correction in cardio-renal syndrome; leaves open confirmation of LVEF and GFR benefits in RCTs.
Does correction of anaemia with erythropoietin and iron improve cardiac and renal outcomes in patients with cardio-renal anaemia syndrome?
The cardio-renal anaemia syndrome represents a vicious cycle where anaemia, CHF, and CKI exacerbate each other, and treating the anaemia can improve both cardiac and renal outcomes.
D.S. Silverberg (2003) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: